Vicks Action 500
-
{
- All
- News
- Videos
-
Court Reserves Verdict On Pleas Against Ban On 344 Drugs
The Delhi High Court on Thursday reserved its verdict in over 450 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well-known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.
-
P&G to Resume Vicks Action 500 Extra Manufacturing, Sale
FMCG firm Procter and Gamble (P&G) on Wednesday said it will resume manufacturing and sale of its popular brand 'Vicks Action 500 Extra' after the Delhi High Court stayed government's order banning fixed dose combination drugs.
-
P&G to Challenge Ban on Vicks Action 500 Extra
US consumer health group Procter & Gamble's Indian business plans to challenge a government ban on its cough-and-cold medicine Vicks Action 500 Extra, citing potential health risks.
-
Procter & Gamble Stops Selling Vicks Action 500 Extra in India After Ban
U.S. consumer health giant Procter & Gamble's India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.
-
Pfizer, Abbott, Procter & Gamble Shares Hit By Drug Ban
Pfizer shares were headed for their second successive fall on Tuesday following following a ban on its Corex cough syrup. Pfizer shares sank 9 per cent yesterday.
-
Court Reserves Verdict On Pleas Against Ban On 344 Drugs
The Delhi High Court on Thursday reserved its verdict in over 450 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well-known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.
-
P&G to Resume Vicks Action 500 Extra Manufacturing, Sale
FMCG firm Procter and Gamble (P&G) on Wednesday said it will resume manufacturing and sale of its popular brand 'Vicks Action 500 Extra' after the Delhi High Court stayed government's order banning fixed dose combination drugs.
-
P&G to Challenge Ban on Vicks Action 500 Extra
US consumer health group Procter & Gamble's Indian business plans to challenge a government ban on its cough-and-cold medicine Vicks Action 500 Extra, citing potential health risks.
-
Procter & Gamble Stops Selling Vicks Action 500 Extra in India After Ban
U.S. consumer health giant Procter & Gamble's India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.
-
Pfizer, Abbott, Procter & Gamble Shares Hit By Drug Ban
Pfizer shares were headed for their second successive fall on Tuesday following following a ban on its Corex cough syrup. Pfizer shares sank 9 per cent yesterday.
